Bessemer Group Inc. increased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) by 2.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 144,545 shares of the biotechnology company's stock after acquiring an additional 3,096 shares during the